<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药筛 | wechat-feeds</title><link>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</link><description>药品筛选</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 25 Jan 2021 21:09:16 +0800</pubDate><image><url>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</url><title>药筛 | wechat-feeds</title><link>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>普瑞巴林口服液首仿上市，右美托咪定多家过评价 | 上周仿制药动态（1.18-1.24）</title><link>https://mp.weixin.qq.com/s/b-Fldfljb5hAta9YXpe5BQ</link><description></description><content:encoded><![CDATA[普瑞巴林口服液首仿上市，右美托咪定多家过评价 | 上周仿制药动态（1.18-1.24）]]></content:encoded><pubDate>Mon, 25 Jan 2021 15:26:05 +0800</pubDate></item><item><title>默克寄予厚望的PD-L1/TGFβ双抗，肺癌三期临床试验失败</title><link>https://mp.weixin.qq.com/s/EB8O-4ABQpT7aZP7KRrJQA</link><description></description><content:encoded><![CDATA[默克寄予厚望的PD-L1/TGFβ双抗，肺癌三期临床试验失败]]></content:encoded><pubDate>Fri, 22 Jan 2021 18:26:22 +0800</pubDate></item><item><title>普瑞巴林口服液、泊沙康唑肠溶片首仿来了</title><link>https://mp.weixin.qq.com/s/YLIejEKuwTkDXf0MnmWBsw</link><description></description><content:encoded><![CDATA[普瑞巴林口服液、泊沙康唑肠溶片首仿来了]]></content:encoded><pubDate>Thu, 21 Jan 2021 19:17:16 +0800</pubDate></item><item><title>这个4+7集采独家中标品种，将新增3个企业过评价</title><link>https://mp.weixin.qq.com/s/GGawI9ELbo_8IQoizIL8cw</link><description></description><content:encoded><![CDATA[这个4+7集采独家中标品种，将新增3个企业过评价]]></content:encoded><pubDate>Wed, 20 Jan 2021 19:06:43 +0800</pubDate></item><item><title>广撒网策略：科伦仿制药品种线不断壮大</title><link>https://mp.weixin.qq.com/s/GSSvNUTOC0R9nw44od4q7g</link><description></description><content:encoded><![CDATA[广撒网策略：科伦仿制药品种线不断壮大]]></content:encoded><pubDate>Tue, 19 Jan 2021 19:00:37 +0800</pubDate></item><item><title>扬子江药业 丙泊酚中/长链脂肪乳过评价 | 上周仿制药动态（1.11-1.17）</title><link>https://mp.weixin.qq.com/s/65aTAYWyjHo65tx7mu2oZw</link><description></description><content:encoded><![CDATA[扬子江药业 丙泊酚中/长链脂肪乳过评价 | 上周仿制药动态（1.11-1.17）]]></content:encoded><pubDate>Mon, 18 Jan 2021 14:04:19 +0800</pubDate></item><item><title>罗欣1类新药替戈拉生片上市申请，几个小而美仿制药将获批</title><link>https://mp.weixin.qq.com/s/-YvAz3bP6Hjli-RpApC69Q</link><description></description><content:encoded><![CDATA[罗欣1类新药替戈拉生片上市申请，几个小而美仿制药将获批]]></content:encoded><pubDate>Fri, 15 Jan 2021 17:33:01 +0800</pubDate></item><item><title>鸡贼和地方带量采购</title><link>https://mp.weixin.qq.com/s/MGqe4Z8XGhbptHtuGzaJCw</link><description></description><content:encoded><![CDATA[鸡贼和地方带量采购]]></content:encoded><pubDate>Thu, 14 Jan 2021 19:56:43 +0800</pubDate></item><item><title>国内首个CAR-T疗法，即将上市；多个重磅注射剂通过一致性评价</title><link>https://mp.weixin.qq.com/s/BVhDkcmTeK1ARHkyoJOG3w</link><description></description><content:encoded><![CDATA[国内首个CAR-T疗法，即将上市；多个重磅注射剂通过一致性评价]]></content:encoded><pubDate>Tue, 12 Jan 2021 20:07:58 +0800</pubDate></item><item><title>罗哌卡因、舒芬太尼、瑞芬太尼等多个麻醉镇痛药过评价 | 上周仿制药动态（1.4-1.10）</title><link>https://mp.weixin.qq.com/s/xE3b58EdR_TJsxS9MbfN7Q</link><description></description><content:encoded><![CDATA[罗哌卡因、舒芬太尼、瑞芬太尼等多个麻醉镇痛药过评价 | 上周仿制药动态（1.4-1.10）]]></content:encoded><pubDate>Mon, 11 Jan 2021 17:22:33 +0800</pubDate></item></channel></rss>